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Abstract.  In neuronal and endocrine cells, peptide 
hormones are selectively segregated into storage gran- 
ules, while other proteins are exported continuously 
without storage.  Sorting of hormones by cellular ma- 
chinery involves the recognition of specific structural 
domains on prohormone molecules. Since the propep- 
tide of insulin is known to play an important role in 
its three-dimensional structure, it is reasonable to 
speculate that targeting of proinsulin to storage gran- 
ules would require a  functional connecting peptide.  To 
test this hypothesis, we constructed two mutations in 
human proinsulin with different predicted structures. 
In one mutation, InsAC, the entire C  peptide was de- 
leted, resulting in an altered insulin in which the B 
and the A  chains are joined contiguously. In the other 
mutation, Ins/IGF, the C  peptide of proinsulin was 
replaced with the unrelated 12-amino acid connecting 
peptide of human insulin-like growth factor-l; this sub- 
stitution should permit correct folding of the B and A 
chains to form a  tertiary structure similar to that of 
proinsulin.  By several biochemical and morphological 
criteria, we found that Ins/IGF is efficiently targeted to 
storage granules,  suggesting that the C  peptide of pro- 
insulin does not contain necessary sorting information. 
Unexpectedly, InsAC,  which presumably cannot fold 
properly, is also targeted to granules at a  high effi- 
ciency. These results imply that either the targeting 
machinery can tolerate changes in the tertiary structure 
of transported proteins,  or that the B and A  chains of 
insulin can form a  relatively intact three-dimensional 
structure even in the absence of C  peptide. 
S 
PECIALI  Z ED secretory cells, such as neural and endo- 
crine cells, have two secretory pathways; a constitutive 
pathway by which proteins are exported to the cell sur- 
face  directly  after  synthesis and  a  regulated  pathway by 
which peptide hormones and neuropeptides are targeted to 
dense core secretory granules, where they are stored until re- 
lease is stimulated by secretagogues (for reviews see 14, 22). 
Recent work  suggests  that peptide hormones are  actively 
sorted into dense core secretory granules, whereas constitu- 
tive proteins appear to be transported to the cell surface by 
a bulk-flow process (for review see 22, 32).  When a regu- 
lated secretory protein, human growth hormone, is fused to 
a constitutively secreted viral protein, TG (soluble VSV-G), 
the hybrid protein is routed to regulated secretory granules 
(20). This suggests that a positive targeting signal is encoded 
within  the  structure  of regulated  proteins.  However,  se- 
quence comparisons of several  proteins targeted to dense 
core secretory granules do not reveal primary sequence ho- 
mology that could serve as a common signal for targeting to 
granules. It is also unknown to what extent the sorting signal 
depends on the integrity of prohormones' tertiary structure. 
Signals for sorting of proteins to other organelles have 
been identified by analysis of mutated proteins; these results 
suggest that sequences  which are  cleaved from precursor 
proteins during intracellular transport often function as tar- 
geting signals.  The signal sequence that directs  secretory 
proteins to rough endoplasmic reticulum is usually cleaved 
soon  after  nascent  polypeptide  chains  have  translocated 
across the membrane of the rough endoplasmic reticulum 
and sequences required for targeting of vacuolar (12, 39) and 
mitochondrial (11, 34)  proteins  in yeast are  cleaved from 
precursors after the proteins have reached their final intracel- 
lular destination. The biogenesis of many peptide hormones 
also resembles that of vacuolar or mitochondrial proteins: 
they are synthesized as large precursors, and the propeptides 
are cleaved from the hormones after they are packaged into 
secretory granules (7, 25, 26, 28, 38). These proregions are 
usually biologically inactive and, in the case of insulin, are 
known to play a major structural role in polypeptide folding 
and disulfide bond formation (35, 40).  Whether these pro- 
peptides also contain targeting information or whether they 
are essential for folding prohormones into structures recog- 
nizable by the sorting machinery is currently unknown. 
To test the role of proregions in the localization of hor- 
mones to dense core granules, we have chosen to study the 
C peptide of proinsulin. Insulin is structurally and biochemi- 
cally well characterized and is synthesized as a  precursor 
consisting of three distinct regions: B, C, and A chains (30, 
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duced by processing at pairs of basic amino acid residues 
flanking the C peptide, resulting in a mature form in which 
the B and A chains are joined together by two disulfide bonds 
(for reviews of insulin structure, see references 8, 13, 16, 35, 
36). We constructed two mutated proinsulins with drastic al- 
terations in the C peptide and compared their ability to be 
targeted to the regulated pathway with that of wild-type pro- 
insulin. In the first mutation, InsAC, the entire C peptide, 
including the proteolytic processing sites,  was deleted, re- 
suiting in the direct fusion of the B chain to the A chain. It 
is reasonable to assume that this molecule may not adopt the 
native conformation of mature insulin since in vitro studies 
suggest that the  C  peptide of proinsulin is  necessary for 
proper  polypeptide  folding and disulfide bond  formation 
(35).  This deletion might affect sorting in two ways: either 
the signal is a part of the deleted sequences or the signal re- 
sides in another part of the molecule but becomes obscured 
as a result of structural changes induced by the deletion. For 
comparison, we constructed another mutation in which the 
sequence encoding the C peptide of proinsulin was replaced 
by  the  sequence  encoding  the  C  peptide  of insulin-like 
growth factor I (IGF-I). 
Human IGF-I consists of B and A chains that are 45 % ho- 
mologous to the B and A chains of  human insulin but are con- 
nected by a  12-amino acid C peptide unrelated to the 34- 
amino acid C  peptide of proinsulin.  All six cysteines in- 
volved in insulin disulfide bond formation are conserved in 
the IGFs, and, despite the differences in the C peptide, the 
overall three dimensional structure of IGF-I is similar to that 
of proinsulin. Additionally, hybrid proteins made by mixing 
individual chains from the two proteins have been shown to 
be biologically active (Fig. 1; also see references 3, 6, 8, 17). 
IGF-I is secreted primarily by liver cells, which do not have 
dense core secretory granules; it is not known whether IGF-I 
is targeted to dense core granules in other tissues (8). There- 
fore, substitution of the C peptide of  proinsulin with the IGF- 
I C peptide should allow us to assess the sorting information 
contained within the proinsulin C peptide with minimal per- 
turbation of the molecule's three dimensional structure. The 
predicted structure of the Ins/IGF hybrid protein is shown in 
Fig.  1 D. 
In this study, we examined the effect of these mutations on 
intracellular transport of proinsulin. We describe results ob- 
tained by the following analysis: (a) the ability of cAMP ana- 
logues to stimulate secretion, (b) detection of variant insulins 
in dense granules isolated on D20-Ficoll gradients, and (c) 
analysis of the intracellular location of these proteins by in- 
direct immunofluorescence  and immunoelectron  microscopy. 
Materials and Methods 
Antisera, Hormones, Enzymes, and Primers 
Affinity-purified rabbit anti-porcine ACTH was prepared as previously de- 
scribed (18). Guinea pig anti-porcine insulin antiserum was obtained from 
Linco Research, Inc. (Eureka, MO). Hybridoma HB 125, which recognizes 
amino acids 8-10 of the A chain of human insulin, was obtained from Amer- 
ican Type Culture Collection (Rockville, MD). Rhodamine and fluorescein 
antibodies were from Cappell  Laboratories (Malvern,  PA).  Insulin and 
ACTH for RIA standards were from Sigma Chemical Co. (St. Louis, MO). 
1. Abbreviation  used in this paper:  IGF-I, insulin-like growth factor I. 
[L25IIACTH and [125I]insulin for RIA were supplied by the Metabolic Re- 
search Unit, University of California, San Francisco. Primers for mutagene- 
sis and for sequencing were purchased from the Biomolecular Resource 
Center, University of  California, San Francisco. Klenow fragment and poly- 
nucleotide kinase were obtained from Boehringer Mannheim Biochemicals 
(Indianapolis, IN). [ct-32P]dCTP for sequencing was obtained from Amer- 
sham Corp. (Arlington Heights, IL) and [~,32P]dATP for end-labeling oli- 
gonucleotide primers was obtained from New England Nuclear (Boston, 
MA). Restriction enzymes and T4 DNA ligase were obtained from New En- 
gland Biolabs (Beverly,  MA). 
Mutagenesis 
Both insulin mutations were constructed by oligonucleotide-directed muta- 
genesis. The mutagenic 64-mer used for construction of the insulin-lGF hy- 
brid gene was complementary to the 14 base pairs at the 3' end of the B chain 
and the 14 base pairs at the 5' end of the A chain joined by 36 base pairs 
complementary to the C peptide of human IGF-I. This primer was annealed 
to a human proinsulin template in M13. The C peptide deletion mutagenesis 
was carried out in an identical manner, using a  mutagenic 30-mer com- 
plementary to the 15 base pairs at the 3' end of the B chain and the 15 base 
pairs at the 5' end of the A chain. Primer extension with Klenow fragment 
and screening for mutations were carried out according to procedures of 
Zoller and Smith (41). Mutations were confirmed by dideoxy sequencing 
(33). The mutated proinsulin sequences were subcloned from the MI3 vec- 
tor into an expression vector, pRSV-poly, which contained the RSV-LTR as 
a  promoter (described in reference 21). For  subeloning,  M13  RFs were 
digested with Nco I and Barn HI, and the fragment containing the mutated 
proinsulin cDNA was gel purified using an Elutip column (Schleicher & 
Schuell Inc., Keene, NH).  100 ng of RSV vector was digested with Nco I 
and Bgl II, treated with calf intestinal phosphatase (Boehringer Mannheim 
Biochemicals, Indianapolis, IN), and ligated with 100 ng of purified frag- 
ment.  Enzymes were removed from reaction mixtures by phenol-chloro- 
form extraction and DNA was recovered by ethanol precipitation. 
Cell Culture and Transfection 
AtT-20 cells were grown in  15%  CO2  in DME H21  supplemented with 
10% FCS and 100 U/ml penicillin/streptomycin. DNA transfection was car- 
ried out by a  modified calcium phosphate precipitation procedure as de- 
scribed previously (23).  Cells were cotransfected with  120 I.tg of pRSV- 
InsAC or pRSV-Ins/IGF and 24 I-tg  of the plasmid pSV2-neo-encoding bac- 
terial phosphotransferase which confers neomycin resistance. Stable clones 
were selected with the antibiotic, G418 (geneticin; Gibco, Grand Island, 
NY) at a concentration of 0.25  mg/ml active drug. Clones were screened 
for expression by insulin RIA or by labeling cells with [35S]cysteine and 
immunoprecipitation with polyclonal antiinsulin antisera. ACTH RIA and 
solid-phase insulin RIA were as described previously (23). 
Immunocytochemistry 
For immunocytochemistry, glass coverslips were first coated with 1 mg/ml 
poly-o-lysine for 1-2 h at room temperature, washed thoroughly with dis- 
tilled water, and then coated with 5 I.tg/ml laminin (Gibco) for 12 h at 4°C. 
One coverslip was placed in each well of a 6-well dish and 1  x  105 cells 
were plated per well and grown for 48 h before immunostaining. Cells were 
fixed in 3.7% formaldehyde in PBS for 30 min at room temperature, rinsed 
in PBS plus 0.1 M glycine, and permeabilized in PBS/0.1% Triton X-100 for 
5 min at room temperature. For ACTH staining, cells were reacted with a 
1:20 dilution of affinity-purified rabbit anti-ACTH, followed by a 1:50 dilu- 
tion of rhodamine-conjugated goat anti-rabbit antibody. For insulin stain- 
ing, culture supernatant from hybridoma HB 125 was collected and concen- 
trated fivefold by centrifugation through a Centricon 10 filter according to 
the manufacturer  (Amicon Corp.,  Danvers, MA).  Fixed, permeabilized 
cells were reacted with concentrated supernatant, followed by 1:150 dilu- 
tions of fluorescein-conjugated goat anti-mouse antibody and fluorescein- 
conjugated rabbit anti-goat antibody applied sequentially. All antibodies 
were diluted in PBS/0.1  M glycine. Incubations were carried out at room 
temperature  for 30  rain  and  were  followed by  three  10-min  washes  in 
PBS/0.1  M  glycine. Coverslips were mounted onto slides with  10  pA of 
1,4-diazobicyclo(2,2,2)octane in 90%  glycerol/PBS. 
For thin section immunocytochemistry, AtT-20 cells were fixed with 1% 
glutaraldehyde buffered in 0.1 M phosphate, pH 7.4, dehydrated with etha- 
nol, and embedded in Lowicryl K4M at low temperature (1). The sections 
were collected on nickel grids and immunolabeled with the polyclonal an- 
tiinsulin serum (1:1,000) revealed by the protein A-gold method (31). 
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Immunoprecipitation  and Quantitation  of  Sorting Index 
Selected stable transfectants were labeled for 15 h with 0.5 mCi of [35S]cys- 
teine (Amersham Corp.) in cysteine-free DME supplemented with 2 % FCS 
(3  ml media/10-cm dish).  The sorting index was then determined as de- 
scribed previously (19).  In brief, the 15-h labeling media was removed and 
the steady-state rate of secretion (N) was measured by incubating the cells 
with labeling medium for an additional hour. Cells were then rinsed with 
complete DME supplemented with 2 % FCS and chased in this medium for 
three 3-h periods. During the last chase (6-9 h), 5 mM 8-Br-cAMP (Sigma 
Chemical Co.) was added to one dish to induce release from regulated secre- 
tory granules. Media and cell extracts were harvested, subjected to double 
immunoprecipitation, and analyzed on 10-18 % SDS-polyacrylamide gels as 
described  (20).  For  quantitation  of sorting  index,  autoradiograms were 
scanned and the area under the peaks was determined. 
Isolation of  Dense Core Secretory Granules 
Secretory granules were  isolated from AtT-20 clones expressing Ins/IGF 
and InsAC on D,O-Ficoll gradients as described (9). Cells were harvested 
from three confluent 15-cm tissue culture dishes using PBS/5 mM EDTA. 
The cell pellet was resuspended in  15 ml cold homogenization buffer (250 
mM sucrose, 10 mM Hepes, pH 7.4, 2 mM EGTA, 1 mM EDTA) and cells 
were  homogenized in  a  ball-bearing  homogenizer (European  Molecular 
Biology Laboratory, Heidelberg,  Federal Republic of Germany; chamber, 
8.020 mm, bearing, 8.004 mm) 1 ml at a time, 6 strokes/ml. The postnuclear 
supernatant was fractionated on a  D20/Ficoll gradient and fractions were 
analyzed by ACTH RIA as previously described (9). For insulin RIA of gra- 
dient fractions, 50 lal of each fraction was diluted to 900 I~1 in 50 mM so- 
dium phosphate buffer, pH 7.4, 0.5% BSA (Sigma Chemical Co.; fraction 
V), 0.5%  NP-40 and boiled for  1 min to release proteins from membrane 
fractions. Insulin standards were prepared in 900 ktl of the same buffer. 100 
lal of a  1:15,000 dilution of guinea pig anti-porcine insulin antisera and 5 
111 [125I]insulin (40 I.tg/ml) in 50 mM sodium phosphate, pH 7.4/0.5% BSA 
was added to the samples and incubated for 12 h at 4°C. 1 p.I of fixed Staphy- 
lococcus aureus  (Pansorbin; Calbiochem-Behring Corp.,  San Diego, CA) 
cells was added to the reaction mixture and incubated for 30 min at room 
temperature with shaking. Cells were pelleted at  1,700 g  for  10 min, and 
the amount of cell-associated [t25I]insulin  was determined by counting the 
pellets in a  gamma counter. 
Results 
Strategy and Construction of  Mutated Proinsulins 
To determine if the C peptide of proinsulin contains the tar- 
geting signal for the regulated pathway,  we constructed two 
mutations in  the human proinsulin cDNA by oligonucleo- 
tide-directed mutagenesis.  To construct a  mutation lacking 
the entire C peptide (InsAC), we deleted the sequence en- 
coding  the  C  peptide  region  from  the  proinsulin  cDNA, 
directly  joining the sequence encoding the B peptide with the 
sequence encoding the A peptide (see Fig. 2). Since this mu- 
tation also  removed the  two prohormone processing sites 
flanking the C peptide, we predicted that the protein encoded 
by this  DNA  should  not be proteolytically processed and 
should be synthesized as a single polypeptide chain contain- 
ing both B and A  sequences. In the second mutation, Ins/ 
IGF, the C peptide of insulin was replaced with the 12-amino 
acid connecting peptide of IGF-I (see Fig. 2). The C peptide 
of IGF-I is not flanked by pairs of basic residues and is not 
proteolytically processed from the molecule; thus, Ins/IGF 
also should be synthesized and secreted as a single polypep- 
tide chain.  Fig.  2  shows  the construction of both mutated 
proinsulins  in an M13 vector and their subcloning into an 
RSV  vector for expression in AtT-20 cells.  The entire se- 
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Figure 2.  Construction of Ins/IGF and InsAC. Both insulin muta- 
tions  were  constructed  by  oligonucleotide-directed  mutagenesis 
(41). Primers were annealed to a wild-type insulin template cloned 
in M13. For Ins/IGF, a mutagenic 64-mer was used to replace the 
region complementary to the C peptide of human insulin with a re- 
gion complementary to the C peptide of  IGF-I. A mutagenic 30-mer 
complementary  to the  desired  junction  regions  of the  B  and  A 
chains was used to delete the C peptide. The entire sequence of  both 
mutated genes was confirmed by the dideoxy method (33). Mutated 
fragments were subcloned from mp vectors on Nco I-Barn HI frag- 
ments and ligated into Nco I-Bgl II-digested RSV vector. The fol- 
lowing cloning sites had been inserted in the vector at the 3' end 
of the  long  terminal  repeat:  Hind  III-Xba I-Nco I-Eco RI-Sma 
I-Bgl II. 
quences of Ins/IGF and InsAC were confirmed by DNA se- 
quence analysis using the dideoxy method (data not shown). 
Expression and Secretion of  Mutated Proinsulins 
in AtT-20 Cells 
The effects of mutations on sorting were analyzed in mouse 
pituitary AtT-20 cells.  Previously, we have shown that this 
cell  line correctly  sorts transfected human proinsulin  into 
dense secretory granules and processes it to mature insulin 
(23). AtT-20 cells were cotransfected with plasmids carrying 
the mutations described above and the plasmid pSV2-neo, 
which confers neomycin resistance. Stable transfectants were 
obtained by selection in 0.25 mg/ml G418. Clones surviving 
the  selection  were  screened  by  insulin  RIA.  Since  the 
amount of nonselectable DNA was in large excess over se- 
lectable  DNA,  "-75%  of selected  G418-resistant  colonies 
Figure 3. Expression and secretion of insulin and mutants in AtT-20 
cells.  Cells  were labeled  for 16 h with  [35S]cysteine. Media  and 
cell extract samples were immunoprecipitated with a polyclonal in- 
sulin  antibody  as  described  (19). Lanes  1  and  2,  extract  and 
medium from untransfected AtT-20 cells; lanes 3 and 4, extract and 
medium from ceils transfected with wild-type proinsulin;  lanes 5 
and  6,  extract and medium  from cells transfected with Ins/IGF; 
lanes  7 and  8,  extract  and  medium  from cells  transfected  with 
InsAC.  The high  molecular  mass bands  in lanes 5  and  7 were 
nonspecific and were not reproducible  between experiments. 
also expressed the insulin variants. The cell lines used for the 
following experiments produced 10-70 ng of immunoreactive 
insulin/3  ×  106 cells per 48 h, which is typical of the level 
of expression from an RSV-driven promoter in AtT-20 cells. 
These cells produce the  endogenous hormone ACTH at a 
much higher level;  '~2 lag/3  ×  106 cells per 48 h. 
Both mutated proinsulins were synthesized and secreted by 
AtT-20 cells.  Transfected cells were metabolically labeled 
with [35S]cysteine for 16 h, and cell extract and media sam- 
ples were immunoprecipitated with a guinea pig antiinsulin 
antiserum  and analyzed on  reducing  SDS-polyacrylamide 
gels (Fig. 3). Lanes 3 and 4 show extract and media samples 
from cells transfected with wild-type proinsulin DNA. Two 
polypeptides were immunoprecipitated from both media and 
extracts: the upper 9.5-kD polypeptide is proinsulin, and the 
lower 6.0-kD band contains the B and the A chains of mature 
insulin (the two chains are unresolved under these gel condi- 
tions). Note that in the absence of stimulation, proinsulin is 
secreted constitutively and  is the predominant form in  the 
media. Mature insulin is the predominant form found in the 
cell extract; it is stored intracellularly until release is stimu- 
lated (Fig.  3,  lanes 3  and 4;  also  see reference 23).  Cells 
transfected with the Ins/IGF plasmid synthesize and secrete 
a major polypeptide migrating at '-7.5 kD, the predicted mo- 
lecular mass of the insulin-IGF hybrid (lanes 5  and 6).  A 
minor band  migrating just  below the  7.5-kD  band  is  also 
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Ins/IGF gene. Pulse-chase experiments show that these two 
proteins do not have a precursor-product relationship (data 
not shown); hence the lower band could be a degradative 
product of the 7.5-kD protein during isolation. In cells ex- 
pressing the InsAC plasmid, extract and media samples con- 
tain a single polypeptide that migrates slightly faster than the 
Ins/IGF hybrid at •7.0  kD, which is the predicted molecular 
mass of B plus A chain (lanes  7 and 8). 
As discussed earlier, Ins/IGF is expected to fold similarly 
to proinsulin and form proper disulfide linkages; in vitro 
studies using short synthetic cross-linkers to join the B and 
A chains of insulin also enable the formation of the correct 
structure (40).  In support of this, we found that reduction of 
Ins/IGF with mercaptoethanol results in a decrease in the 
mobility on SDS-polyacrylamide gels that is similar to the 
decrease observed for proinsulin (data not shown). In con- 
trast, reduction oflnsAC did not produce a comparable shift 
in mobility (data not shown). 
Although both Ins/IGF and InsAC can be detected in the 
culture supernatant from unstimulated cells, the majority of 
the labeled polypeptide was found in the cell extracts (Fig. 
3). The slow release of  these proteins in the absence of stimu- 
lation indicates that they might be stored in dense core gran- 
ules. However,  it is also possible that these genetically al- 
tered proteins do not fold correctly and are retained in the 
endoplasmic reticulum. These different possibilities are ex- 
amined below. 
Intraceilular Localization by lmmunocytochemistry 
To determine where the variant insulins are located within 
the cell, we first examined the cells by indirect immunofluo- 
rescence. AtT-20 cells grown on laminin extend long pro- 
cesses, and dense core granules are concentrated in the tips 
of processes and also are located at the periphery of these 
cells (Rivas, R., and H. P. Moore, unpublished data; also see 
reference 15). Cells stained with anti-ACTH antibodies re- 
vealed punctate staining in the cytoplasm and intense fluores- 
cence at the tips of processes (Fig. 4 A).  Proinsulin trans- 
fected into AtT-20 cells is packaged in the same granules as 
ACTH and shows a similar staining pattern (27). In contrast, 
a soluble form of the vesicular stomatitis virus G protein that 
is  known to  be  secreted by the  constitutive pathway (19) 
shows diffuse cytoplasmic staining; no visible staining could 
be detected in the processes  (Fig.  4 B;  see arrows). This 
staining most likely represents the rough endoplasmic reticu- 
lum, since the majority of this protein inside the cell has en- 
doglycosidase H-sensitive oligosaccharides (19). When cells 
expressing either Ins/IGF (Fig. 4  C) or InsAC (Fig. 4 D) 
were stained with an mAb that recognizes both proinsulin 
and mature insulin, the distribution of immunoreactive sites 
resembled that of ACTH and wild-type insulin; the most in- 
tense staining was found at the tips of processes. The mutated 
insulins  also  showed  some  staining  of  the  juxtanuclear 
regions which was not observed for ACTH staining. This is 
due to the poor reactivity of the ACTH serum against the 
precursor  POMC  and  consequent  lack  of Golgi  staining 
(Orci,  L., and H. P. Moore, unpublished data). 
To determine the subcellular localization of the mutated 
insulin InsAC, we stained thin sections for electron micros- 
copy with a polyclonal antiinsulin serum revealed by the pro- 
tein A-gold technique.  Insulin immunoreactivity was  dis- 
tinctly and specifically located over dense core  secretory 
granules (Fig. 5). 
Response to Stimulation by cAMP 
As described above, immunocytochemistry  revealed that the 
mutated insulins are  located  within dense core  secretory 
granules.  To  quantitate  the  efficiency at  which  they  are 
sorted, we measured the "sorting index" according to a la- 
bel-chase protocol described previously, which measures 
the relative increase in the rate of secretion when cells are 
stimulated by secretagogues (19). Since only proteins tar- 
geted to granules are responsive to 8-Br-cAMP,  the extent of 
secretagogue-induced secretion relative to basal secretion is 
a measure of the efficiency at which a protein is targeted to 
the regulated pathway. Fig. 6 shows a comparison of media 
samples collected from control cells and from cells stimu- 
lated with 8-Br-cAMP.  Secretion of both Ins/IGF and InsAC 
is strongly stimulated by 8-Br-cAMP (compare lanes 1 and 
3,  stimulated, to lanes 2 and 4, unstimulated). Calculation 
of sorting indices shows that Ins/IGF and InsAC are effi- 
ciently sorted into the regulated pathway: wild-type human 
proinsulin  has  a  sorting  index of 0.66, and  Ins/IGF and 
InsAC have higher sorting indices of 2.2 and 4.4, respec- 
tively (Table I). All three proteins are sorted with efficiencies 
at least two orders of magnitude higher than constitutive 
secreted  proteins  (e.g.,  sorting  index  of soluble VSV-G, 
0.002-0.006,  see reference 19). The higher sorting indices of 
the mutated proteins are not a result of higher sorting capa- 
bility of  the isolated clones, since analysis of the sorting indi- 
ces of ACTH in these cells shows that they are similar to that 
of untransfected cells (data not shown). The mutant proteins 
are stable within the cell and in the medium; the radioactivity 
incorporated during the labeling period can be quantitatively 
recovered at the end of the 9-h chase period (data not shown). 
Thus, the high sorting indices of the mutated proteins are not 
a result of differential stabilities in certain cellular compart- 
ments. 
Biochemical Fractionation of  Dense Core 
Secretory Granules 
The results of both immunofluorescence and labeling experi- 
ments described above indicate that Ins/IGF and InsAC are 
targeted to the regulated pathway. To further demonstrate that 
the mutated proteins are stored in dense-core secretory gran- 
ules, unstimulated cells were homogenized and fractionated 
on  D20-Ficoll  gradients  (Fig.  7).  As  shown  previously, 
dense core secretory granules have a  high protein content 
and can be separated from other cellular organelles on this 
gradient (9).  Since AtT-20 cells store the endogenous hor- 
mone ACTH in dense core granules, we assayed the gra- 
dients by an ACTH RIA to determine where dense core gran- 
ules migrate, The peak of immunoreactivity migrating close 
to the bottom of the gradient (fractions 2-6) represents dense 
core granules containing mature ACTH, whereas those in the 
middle (see Fig. 7 B, fractions 9-12) and the top of the gra- 
dient are other membranes containing the ACTH precursor, 
POMC (see references 9 and 10;  Figure 7).  To determine 
whether the mutated proinsulins could be detected in dense 
core granule fractions, aliquots from each fraction were also 
assayed by an insulin RIA using a polyclonal insulin antise- 
rum that recognizes both mutated proteins. Fig. 7 A shows 
Powell et al.  Targeting of Mutated Proinsulins  to Granules  1847 Figure 4. Intracellular localization of mutant insulins by indirect immunofluorescence. AtT-20 cells were grown on laminin-coated cover- 
slips, fixed in 3.7% formaldehyde, and permeabilized in 0.1% Triton in PBS. Cells were stained with affinity-purified rabbit anti-ACTH 
or culture supernatant from hybridoma HB 125 which recognizes A8-10 of insulin, followed by fluorescein- or rhodamine-conjugated sec- 
ondary antibodies. (A) Cells expressing InsAC stained with an anti-ACTH antiserum and fluorescein goat anti-rabbit  antisera. Most im- 
munoreactivity is concentrated in the tips of cell processes. (B) Cells expressing a constitutively secreted protein, soluble vesicular stomati- 
tis virus G (19), stained with a rabbit anti-VSV-G  antiserum followed  by fluorescein-conjugated  goat anti-rabbit antibody. Note the abundant 
cytoplasmic fluorescence but the lack of staining in the tips of cell processes (arrows). (C and D) Cells expressing Ins/IGF and InsAC, 
respectively, stained with a mouse mAb (HB 125) followed by fluorescein-conjugated goat anti-mouse  antibodies. Note staining of the 
tips of processes as well as perinuclear Golgi regions. Bar, 40 ~tm. 
that Ins/IGF colocalized to the same fractions at the bottom 
of the gradient as ACTH: a peak of insulin immunoreactivity 
can be clearly identified in fractions containing dense core 
granules. Ceils expressing InsAC also exhibited a prominent 
peak of insulin immunoreactivity in this region (Fig. 7 B). 
A  similar profile was  also obtained from cells expressing 
wild-type proinsulin (data not shown). 
Recovery of each hormone in the granule peak was quanti- 
rated as a percentage of total amount of that hormone present 
in the cell homogenate.  Since the actual yield of granules 
varies from experiment to experiment, for a given gradient 
the recovery of the mutated proteins in granule fractions was 
normalized  to  the  recovery of the  endogenous  hormone 
ACTH. These numbers represent the amount of transfected 
hormone stored in granules relative to the endogenous stored 
hormone ACTH.  The  ratio  of immunoreactive insulin  to 
ACTH recovered in the granules is 1.14 for cells expressing 
wild-type proinsulin,  and  3.5  and 3.0  for cells expressing 
Ins/IGF and InsAC, respectively. Thus, both mutants are tar- 
geted to the granules even more efficiently than wild-type 
insulin. 
Discussion 
Many peptide hormones are synthesized as larger precursors 
which are proteolytically processed during transport. Bio- 
logically inactive propeptide(s) (such as the C peptide of in- 
sulin) are often copackaged into granules and released with 
active hormones. Copackaging of propeptides into granules 
suggests that cleavage occurs after precursors have already 
been  imported  into  granules.  Alternatively,  each  cleaved 
product derived from a precursor may contain a sorting sig- 
nal and may be sorted individually after processing. Recent 
studies indicate that sorting of hormones precedes proteo- 
lytic processing. Proinsulin is converted to mature insulin in 
newly formed acidifying granules that do not contain consti- 
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InsAC cell  labeled  with  antiinsulin 
serum revealed by the protein A-gold 
technique.  The  field  shows  several 
dense  core  secretory  granules  (ar- 
rows) with a morphology typical of 
this pituitary cell line. Most of the in- 
sulin immunogold particles are con- 
centrated  over  granules.  Minimal 
cellular background  is present over 
the  remainder  of  the  cytoplasm. 
Quantitation of the labeling gives the 
following numbers:  secretory gran- 
ules,  110  4-  8  gold  particles/i.tm  2 
(146 granules evaluated);  mitochon- 
dria  (cellular  background),  3  +  1 
gold  particles/gm~;  secretory gran- 
ules  in  nontransfected  AtT-20 cells 
immunolabeled  in  the  same  condi- 
tion  (control),  4  +  1  gold  parti- 
cles/lam  2  (159 granules  evaluated). 
Number of pictures evaluated,  19. 
Figure 6.  Enhanced secretion 
of mutant  proinsulins  in  re- 
sponse  to  stimulation  by 
cAMP.  Stable  transfectants 
were  labeled  for  16  h  and 
chased  for 6  h.  Shown  here 
are  media  samples  collected 
between 6 and 9 h after label- 
ing  either  in the  presence or 
absence of 5 mM 8-Br cAMP. 
The samples were double im- 
munoprecipitated with an an- 
tiinsulin  antiserum,  run  on 
10-18%  SDS-polyacrylamide 
gels, and prepared for autora- 
diography  as described  (20). 
Note that the amounts of pro- 
teins  analyzed  for  the  two 
clones  shown  in  this  figure 
were not normalized with  re- 
spect to each other. 
tutively  transported  proteins  (25,  27,  28),  and  some  un- 
processed precursor can be detected in dense core granules 
and is released upon stimulation  (29,  38).  These results im- 
ply  that  the  sorting  machinery  recognizes  precursor  hor- 
mones rather than individual mature peptides. Since deletion 
or substitution of the C peptide of proinsulin does not impair 
its  ability  to  be  sorted,  the  sorting  signal  must  be  within 
regions  of the  B  and/or  A  chains  that  are  exposed  in  the 
proinsulin molecule. This domain is therefore different from 
the  domain  that  is  recognized  by the  physiological  insulin 
receptor; the latter recognizes regions of mature insulin that 
are obscured  by the C  peptide  of proinsulin  (13). 
A  surprising  finding  is that both Ins/IGF and InsAC  ap- 
pear to be targeted severalfold more efficiently than proinsu- 
lin in transfected AtT-20 cells.  This could be due to an in- 
crease in the affinity for the sorting machinery as a result of 
removal ofC peptide. Recently, it has been demonstrated that 
some proteins contain multiple functional  signals for target- 
ing  to an organelle,  and  that  the  efficiency of targeting  in- 
creases  with  an increasing  number of signals  (2,  30).  It is 
possible that the C  peptide contains a  redundant  signal that 
is sufficient but not required for targeting. However, this pos- 
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of Mutant Pro#tsulins 
Protein  Sorting index 
Human proinsulin  0.66 
Ins/IGF  2.20 
InsAC  4.40 
Selected stable transfectants were labeled for  15 h  with 0.5 mCi of [35S]cys- 
teine in cysteine-free DME supplemented with 2%  FCS  (3  ml media/10-cm 
dish). The labeling media was removed and the steady-state rate of secretion 
was measured by incubating the cells with labeling medium for an additional 
hour. Cells were then rinsed with complete DME supplemented with 2% PCS 
and chased in this medium for three 3-h periods. During the last chase (6-9 h), 
5 mM 8-Br-cAMP was added to one dish to induce release from regulated secre- 
tory granules. Media and cell extracts were harvested, subjected to double im- 
munoprecipitation, and analyzed on 10-18%  SDS-polyacrylamide gels as de- 
scribed (20).  Sorting indices were determined as follows: 
(secretion/h with cAMP)  -  (secretion/h without cAMP) 
sorting index = 
steady-state secretion/h 
sibility seems unlikely since the efficiency of targeting ap- 
pears to increase rather than decrease when the C peptide is 
removed. It should be noted that these comparisons are made 
in a pituitary tumor cell that normally does not express insu- 
lin. At the present time, we cannot rule out the possibility 
that the high sorting efficiencies of the mutated proteins are 
due to specialized components of the secretory machinery of 
AtT-20 cells. It will be of interest to determine if the mutated 
insulins are also sorted more efficiently when expressed in 
pancreatic cells. 
For vacuolar and mitochondrial enzymes, proteolytic acti- 
vation is concomitant with the removal of targeting signals, 
which reside within the propeptides (11, 12, 39). Presumably, 
removal of targeting signals renders the sorting process irre- 
versible so that the transported proteins will remain in the 
target organelles. In contrast, the targeting signal of proinsu- 
lin is not removed upon arrival at the secretory granules; 
both mutated insulins described here are targeted efficiently 
but do not undergo proteolytic processing. Similarly, Bur- 
gess et al. (5) recently found that the NH2-terminal peptide 
cleaved from the  exocrine protein,  trypsinogen,  does  not 
contain a targeting signal for granules. These results indicate 
that targeting to secretory granules may involve some other 
mechanism to ensure unidirectional transport.  One possi- 
bility,  supported by  an  early observation in  AtT-20  cells 
treated with  chloroquine (21),  is  that the  sorting event is 
made irreversible by the low pH of the secretory granules. 
Instead of removing targeting signals by proteolytic process- 
ing at the target organelle, the low pH of this compartment 
could cause the dissociation of delivered proteins from their 
transporting carriers. 
It has been postulated that the C peptide provides the mini- 
mal length necessary for translocation across the endoplas- 
mic reticulum membrane (35). This possibility is ruled out 
since InsAC is efficiently transported through the secretory 
pathway. Since the C peptide is not essential for either trans- 
location or targeting, its major role is probably in directing 
polypeptide  folding.  This  is  consistent  with  the  recent 
finding that a protein in which the B and A chains of insulin 
are connected by two basic amino acids is not recognized by 
a yeast-processing enzyme (37). In light of this, it is surpris- 
ing that InsAC is efficiently targeted to granules. Our result 
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Figure  7.  Presence of mutated proinsulins  in isolated secretory 
granules. Secretory granules were isolated from AtT-20 clones ex- 
pressing Ins/IGF and InsAC on D20-Ficoll gradients as described 
(9).  The amount of ACTH or insulin-immunoreactive materials 
present in each fraction was determined by RIA and plotted against 
the fraction number. Dense core granule-specific fractions are indi- 
cated (fractions 3-6 for Ins/IGF  and 3-7 for InsAC).  Note that 
ACTH immunoreactive materials were also found in other lighter 
fractions but the exact amounts varied between experiments. These 
fractions have not been characterized, but most likely contain Golgi 
membranes and incompletely homogenized materials. 
implies that the sorting machinery is not sensitive to overall 
structural alterations of insulin. Another intriguing hypothe- 
sis is that sorting does require proper folding of the B and 
A sequences and that InsAC, despite the lack of C peptide, 
is able to form this structure. InsAC is transported efficiently 
through the secretory pathway and, unlike many misfolded 
proteins,  is not associated with the endoplasmic reticulum 
protein,  BiP (reference 4;  see Fig.  3).  This suggests that 
InsAC adopts a native conformation and escapes trapping in 
the  rough  endoplasmic  reticulum.  Analysis  of the  exact 
disulfide bond linkages and the biological activity of InsAC 
will  be  important  in  determining  whether  it  is  folded 
properly. 
A puzzle that still remains to be solved is what comprises 
the common sorting signals of various regulated proteins that 
lack apparent sequence homology. Ogata et al. (24) showed 
recently that  two  intensely  sweet  proteins,  monellin  and 
The Journal of Cell Biology, Volume  106,  1988  1850 thaumatin, which apparently bind to the same receptor and 
are recognized by the same antibodies, have no statistically 
significant sequence homology and do not share similarities 
in three-dimensional crystal structure.  They postulate that 
the common epitope is comprised of many short stretches of 
sequences from different parts of the molecules rather than 
a contiguous stretch of amino acids. It is possible that the 
sorting domain ofproinsulin is similarly formed by short dis- 
continuous segments of the B and A chains. Identification of 
the exact amino acids that contribute to the targeting signal 
will require further mutagenesis of the B and A chains of 
insulin. 
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